Flucelvax Injection, Suspension
Product Images NDC 83703-084

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Flucelvax (NDC 83703-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bamboo Us Bidco Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

L (Flu2t 0007 01)

This is information about the Influenza Vaccine Flucelvax® for the 2025-2026 season. It comes in 0.5 mL pre-filled syringes for intramuscular use and contains no preservatives. The vaccine is made from strains like A/Georgia/12/2022 and B/Singapore/WUH418/2021. It is manufactured by Segirus Inc. in the USA and should be stored between 2-8°C. This vaccine is suitable for individuals aged 6 months and older.*

FDA Label Image

Ty (Flu2t 0007 02)

This is a description of an influenza vaccine named FLUCELVAX® for the 2025-2026 formula. It is intended for use in individuals 6 months of age and older, with a dosage of 0.5 mL. The vaccine is manufactured by Seqirus Inc. and has a US License No. 2049.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.